Uysal, M. Et Al. 2012. Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Uysal, M., Bozcuk, H. S., SEZGİN GÖKSU, S., TATLI, A. M., Arslan, D., Gunduz, S., ... COŞKUN, H. Ş.(2012). Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab . 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Uysal, SEMA Et Al. "Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab," 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2012

Uysal, SEMA S. Et Al. "Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2012

Uysal, M. Et Al. (2012) . "Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={SEMA SEZGİN GÖKSU Et Al. }, title={Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab}, congress name={48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2012}}